We send the latest information from SMC Laboratories.
SMC Laboratories will present a poster at the 267th Kanto Branch Meeting of the Japan Respiratory Society, to …
A research article utilizing our bleomycin-induced pulmonary fibrosis (IPF) mouse model has been published in …
Our clients presented data on treatment of MASH using STAMTM model at the AASLD ~The Liver Metting 2024~ (Nove…
Today, we introduce the pre-clinical studies in MASH drug development targeting Gut-Liver axis. In MASH…
We introduce a case study of drug efficacy evaluation of Mesenchymal stem/stromal cell-derived small extracell…
We would like to introduce a study published by our client using our STAM™ mouse (Dow, et al. Proc Natl Acad S…
Today, we introduce the pre-clinical studies in MASH drug development targeting GLP-1. Speaking of GLP-…
We introduce the pre-clinical studies in MASH drug development using Adiponectin, adipoR1 , adipoR2, etc. as M…
If the therapeutic drug you are developing targets a factor that is related to a multi-organ pathology, such a…
We are pleased to announce that the latest pathology and pathogenesis data in the field of immuno-oncology on …
We introduce a case study of drug efficacy evaluation of anti-claudin-1 antibody using our chronic kidney dise…
SMC is proud to announce that Marshall University (WV) has published the results of their study using our pre-…